Disruptive expression of DKK3 in cancers has been verified in some cancer types, including pancreatic cancer, renal cell carcinoma, thyroid cancer, breast cancer, and colorectal cancer, and downregulated expression of DKK3 has been observed [32–34]. This evidence concerns the gene DKK3 and breast carcinoma.